[Novel anti-obesity drugs]
- PMID: 15732249
[Novel anti-obesity drugs]
Abstract
Obesity is a chronic disease with a worldwide increasing incidence. The mainstay of therapy consists in modification of behaviour related to obesity such as overeating and physical inactivity. When these life-style modifying attempts fail, the use of anti-obesity drugs is warranted. Public health efforts and current anti-obesity agents have not controlled the increasing epidemic of obesity, which has led to an extensive research on novel anti-obesity agents. This review presents an overview on potential future candidates.
Similar articles
-
Treatment modalities of obesity: what fits whom?Diabetes Care. 2008 Feb;31 Suppl 2:S269-77. doi: 10.2337/dc08-s265. Diabetes Care. 2008. PMID: 18227496 Review.
-
[Pharmacotherapy of obesity].Wien Med Wochenschr. 2004 Jul;154(13-14):320-8. doi: 10.1007/s10354-004-0080-1. Wien Med Wochenschr. 2004. PMID: 15368953 Review. German.
-
Addressing the unmet medical need for safe and effective weight loss therapies.Obes Res. 2004 Aug;12(8):1191-6. doi: 10.1038/oby.2004.150. Obes Res. 2004. PMID: 15340099
-
Medical strategies for weight loss in the overweight and obese patient.Minerva Gastroenterol Dietol. 2006 Dec;52(4):415-30. Minerva Gastroenterol Dietol. 2006. PMID: 17108871 Review.
-
Reducing the risk of obesity: defining the role of weight loss drugs.Pharmacotherapy. 2013 Dec;33(12):1308-21. doi: 10.1002/phar.1277. Epub 2013 May 26. Pharmacotherapy. 2013. PMID: 23712541 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical